Want to see JP:4888 full AI Analyst Report?
Total Valuation
STELLA PHARMA CORPORATION has a market cap or net worth of ¥10.95B. The enterprise value is ¥9.93B.
Market Cap¥10.95B
Enterprise Value¥9.93B
Share Statistics
STELLA PHARMA CORPORATION has 36,034,100 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding36,034,100
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
STELLA PHARMA CORPORATION’s return on equity (ROE) is -0.32 and return on invested capital (ROIC) is -17.08%.
Return on Equity (ROE)-0.32
Return on Assets (ROA)-0.17
Return on Invested Capital (ROIC)-17.08%
Return on Capital Employed (ROCE)-0.18
Revenue Per Employee7.35M
Profits Per Employee-17.75M
Employee Count44
Asset Turnover0.07
Inventory Turnover0.06
Valuation Ratios
The current PE Ratio of STELLA PHARMA CORPORATION is ―. STELLA PHARMA CORPORATION’s PEG ratio is -0.07.
PE Ratio―
PS Ratio79.85
PB Ratio10.64
Price to Fair Value10.64
Price to FCF-74.78
Price to Operating Cash Flow0.00
PEG Ratio-0.07
Income Statement
In the last 12 months, STELLA PHARMA CORPORATION had revenue of 323.39M and earned -780.92M in profits. Earnings per share was -22.95.
Revenue323.39M
Gross Profit250.56M
Operating Income-748.96M
Pretax Income-778.00M
Net Income-780.92M
EBITDA-742.15M
Earnings Per Share (EPS)-22.95
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
STELLA PHARMA CORPORATION pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.00
52-Week Price Change-18.96%
50-Day Moving Average401.12
200-Day Moving Average384.85
Relative Strength Index (RSI)40.86
Average Volume (3m)332.29K
Important Dates
STELLA PHARMA CORPORATION upcoming earnings date is Aug 12, 2026, TBA (Confirmed).
Last Earnings DateMay 13, 2026
Next Earnings DateAug 12, 2026
Ex-Dividend Date―
Financial Position
STELLA PHARMA CORPORATION as a current ratio of 16.75, with Debt / Equity ratio of 30.79%
Current Ratio16.75
Quick Ratio11.76
Debt to Market Cap0.03
Net Debt to EBITDA2.80
Interest Coverage Ratio-103.28
Taxes
In the past 12 months, STELLA PHARMA CORPORATION has paid 2.91M in taxes.
Income Tax2.91M
Effective Tax Rate>-0.01
Enterprise Valuation
STELLA PHARMA CORPORATION EV to EBITDA ratio is -32.00, with an EV/FCF ratio of -68.77.
EV to Sales73.44
EV to EBITDA-32.00
EV to Free Cash Flow-68.77
EV to Operating Cash Flow-70.99
Balance Sheet
STELLA PHARMA CORPORATION has ¥2.85B in cash and marketable securities with ¥727.12M in debt, giving a net cash position of ¥2.12B billion.
Cash & Marketable Securities¥2.85B
Total Debt¥727.12M
Net Cash¥2.12B
Net Cash Per Share¥58.90
Tangible Book Value Per Share¥70.06
Margins
Gross margin is 81.91%, with operating margin of -231.60%, and net profit margin of -241.48%.
Gross Margin81.91%
Operating Margin-231.60%
Pretax Margin-240.58%
Net Profit Margin-241.48%
EBITDA Margin-229.49%
EBIT Margin-238.34%
Analyst Forecast
The average price target for STELLA PHARMA CORPORATION is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-66.35%
EPS Growth Forecast-410.00%